JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE)

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 9, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions

Systemic Lupus Erythematosus (SLE)

Interventions

DRUG

JY231 injection

Dose escalation was carried out using the 3+3 principle and the mode of administration was intravenous.

Trial Locations (1)

RECRUITING

920th HJointLogistics, Kunming

All Listed Sponsors

lead

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

OTHER